bat
spit
drug
firm
go
to
market
a
german
firm
whose
main
product
is
deriv
from
the
saliva
of
the
vampir
bat
is
look
to
rais
more
than
m
euro
m
â£m
on
the
stock
market
the
firm
paion
said
that
it
hope
to
sell
million
share
a
third
of
the
firm
for
euro
a
share
it
main
drug
desmoteplas
is
base
on
a
protein
in
the
bat
saliva
the
protein
stop
blood
from
clot
which
help
the
bat
to
drink
from
it
victim
but
could
also
be
use
to
help
stroke
suffer
the
compani
share
go
on
sale
later
thi
week
and
are
schedul
to
start
trade
on
the
frankfurt
stock
exchang
on
februari
if
the
final
price
is
at
the
top
of
the
rang
the
compani
could
be
valu
at
a
much
a
m
euro
the
money
rais
will
be
spent
larg
on
develop
the
compani
other
drug
sinc
desmoteplas
ha
alreadi
been
licens
to
one
manufactur
forest
laboratori
